Abstract
Lawmakers in the US Congress are spending the summer trying to decide how to reform the Food and Drug Administration. The results are likely to set the tone for the agency's regulation ofthe American drug supply for the next decade. Todd Zwillich reports from Washington, DC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have